Gene Delivery
Partnership
Approach
About
News
Blog
Menu
Close
Spun out of George Church's lab, this biotech upstart is mapping the AAV universe for Novartis, Sarepta to gaze
Press
May 11, 2020
Endpoints News
TOC LINK
TOC LINK
Press
Published
May 11, 2020
More like this
The 2020 National Xconomy Awards Winner - Startup of the Year
Press
BioXconomy
September 4, 2020
The 2020 National Xconomy Awards Winner - Startup of the Year
Press
BioXconomy
September 4, 2020
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics Forms New Strategic Partnership With Roche To Advance AAV Gene Therapy Vectors For Neurological Diseases
Announcements
October 24, 2024
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics Launches Dyno eCap 1™ Vector, a Field-Leading AAV Capsid for Eye Gene Therapies
Announcements
October 25, 2023
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
Dyno Therapeutics to Present Breakthrough Data on AAV Gene Delivery to the CNS, Eye, and Muscle at the 28th Annual Meeting of the American Society of Gene & Cell Therapy
Events
April 28, 2025
343 Arsenal St
Watertown, MA 02472
© Dyno 2025
Privacy Policy
Terms + Conditions